Additionally, more research is needed to explore potential modifiers, such as maternal age, coexisting maternal conditions, and gestational age at thrombophilia diagnosis, to provide a more comprehensive understanding of the impact of aPL-associated thrombophilia on pregnancy outcomes. This evidence concerns the gene FASLG and Rare hereditary thrombophilia.